Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Nov 1;319(Pt 3):903–908. doi: 10.1042/bj3190903

Identification of a novel opioid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S1-casomorphin amide).

M Kampa 1, S Loukas 1, A Hatzoglou 1, P Martin 1, P M Martin 1, E Castanas 1
PMCID: PMC1217873  PMID: 8920997

Abstract

A new casomorphin pentapeptide (alpha S1-casomorphin) has been isolated from the sequence of human alpha S1-casein [alpha S1-casein-(158-162)], with the sequence Tyr-Val-Pro-Phe-Pro. This peptide was found to bind with high affinity to all three subtypes of the kappa-opioid receptor (kappa 1-kappa 2). When amidated at the C-terminus, alpha S1-casomorphin amide binds to the delta- and kappa 3-opioid sites. Both alpha S1-casomorphin and its amide inhibit in a dose-dependent and reversible manner the proliferation of T47D human breast cancer cells. This anti-proliferative activity was greater for alpha S1-casomorphin, which was the most potent opioid in inhibiting T47D cell proliferation. In T47D breast cancer cells, other casomorphins have been found to bind to somatostatin receptors in addition to opioid sites. In contrast, alpha S1-casomorphin and its amide do not interact with somatostatin receptors in our system.

Full Text

The Full Text of this article is available as a PDF (370.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson N. G., Powers M. T., Tollaksen S. L. Proteins of human milk. I. Identification of major components. Clin Chem. 1982 Apr;28(4 Pt 2):1045–1055. [PubMed] [Google Scholar]
  2. Bergström S., Hansson L., Hernell O., Lönnerdal B., Nilsson A. K., Strömqvist M. Cloning and sequencing of human kappa-casein cDNA. DNA Seq. 1992;3(4):245–246. doi: 10.3109/10425179209034024. [DOI] [PubMed] [Google Scholar]
  3. Bond J. S., Butler P. E. Intracellular proteases. Annu Rev Biochem. 1987;56:333–364. doi: 10.1146/annurev.bi.56.070187.002001. [DOI] [PubMed] [Google Scholar]
  4. Brantl V., Teschemacher H., Henschen A., Lottspeich F. Novel opioid peptides derived from casein (beta-casomorphins). I. Isolation from bovine casein peptone. Hoppe Seylers Z Physiol Chem. 1979 Sep;360(9):1211–1216. doi: 10.1515/bchm2.1979.360.2.1211. [DOI] [PubMed] [Google Scholar]
  5. Brignon G., Chtourou A., Ribadeau-Dumas B. Preparation and amino acid sequence of human kappa-casein. FEBS Lett. 1985 Aug 19;188(1):48–54. doi: 10.1016/0014-5793(85)80872-3. [DOI] [PubMed] [Google Scholar]
  6. Castanas E., Bourhim N., Giraud P., Boudouresque F., Cantau P., Oliver C. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: I. Interaction with delta and mu sites. J Neurochem. 1985 Sep;45(3):677–687. doi: 10.1111/j.1471-4159.1985.tb04046.x. [DOI] [PubMed] [Google Scholar]
  7. Castanas E., Bourhim N., Giraud P., Boudouresque F., Cantau P., Oliver C. Interaction of opiates with opioid binding sites in the bovine adrenal medulla: II. Interaction with kappa sites. J Neurochem. 1985 Sep;45(3):688–699. doi: 10.1111/j.1471-4159.1985.tb04047.x. [DOI] [PubMed] [Google Scholar]
  8. Chang K. J., Lillian A., Hazum E., Cuatrecasas P., Chang J. K. Morphiceptin (NH4-tyr-pro-phe-pro-COHN2): a potent and specific agonist for morphine (mu) receptors. Science. 1981 Apr 3;212(4490):75–77. doi: 10.1126/science.6259732. [DOI] [PubMed] [Google Scholar]
  9. Chobert J. M., Mercier J. C., Bahy C., Hazé G. Structure primaire du caséinomacropeptide des caséines kappa porcine et humaine. FEBS Lett. 1976 Dec 15;72(1):173–178. doi: 10.1016/0014-5793(76)80838-1. [DOI] [PubMed] [Google Scholar]
  10. Chtourou A., Brignon G., Ribadeau-Dumas B. Quantification of beta-casein in human milk. J Dairy Res. 1985 May;52(2):239–247. doi: 10.1017/s0022029900024109. [DOI] [PubMed] [Google Scholar]
  11. Ferretti L., Leone P., Sgaramella V. Long range restriction analysis of the bovine casein genes. Nucleic Acids Res. 1990 Dec 11;18(23):6829–6833. doi: 10.1093/nar/18.23.6829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Greenberg R., Groves M. L., Dower H. J. Human beta-casein. Amino acid sequence and identification of phosphorylation sites. J Biol Chem. 1984 Apr 25;259(8):5132–5138. [PubMed] [Google Scholar]
  13. Grosclaude F., Joudrier P., Mahé M. F. A genetic and biochemical analysis of a polymorphism of bovine alpha S2-casein. J Dairy Res. 1979 Apr;46(2):211–213. doi: 10.1017/s0022029900017052. [DOI] [PubMed] [Google Scholar]
  14. Hansson L., Edlund A., Johansson T., Hernell O., Strömqvist M., Lindquist S., Lönnerdal B., Bergström S. Structure of the human beta-casein encoding gene. Gene. 1994 Feb 25;139(2):193–199. doi: 10.1016/0378-1119(94)90754-4. [DOI] [PubMed] [Google Scholar]
  15. Hatzoglou A., Bakogeorgou E., Castanas E. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol. 1996 Jan 25;296(2):199–207. doi: 10.1016/0014-2999(95)00703-2. [DOI] [PubMed] [Google Scholar]
  16. Hatzoglou A., Bakogeorgou E., Hatzoglou C., Martin P. M., Castanas E. Antiproliferative and receptor binding properties of alpha- and beta-casomorphins in the T47D human breast cancer cell line. Eur J Pharmacol. 1996 Aug 29;310(2-3):217–223. doi: 10.1016/0014-2999(96)00339-1. [DOI] [PubMed] [Google Scholar]
  17. Hatzoglou A., Gravanis A., Margioris A. N., Zoumakis E., Castanas E. Identification and characterization of opioid-binding sites present in the Ishikawa human endometrial adenocarcinoma cell line. J Clin Endocrinol Metab. 1995 Feb;80(2):418–423. doi: 10.1210/jcem.80.2.7852499. [DOI] [PubMed] [Google Scholar]
  18. Hatzoglou A., Ouafik L., Bakogeorgou E., Thermos K., Castanas E. Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res. 1995 Dec 1;55(23):5632–5636. [PubMed] [Google Scholar]
  19. Hayes H., Petit E., Bouniol C., Popescu P. Localization of the alpha-S2-casein gene (CASAS2) to the homoeologous cattle, sheep, and goat chromosomes 4 by in situ hybridization. Cytogenet Cell Genet. 1993;64(3-4):281–285. doi: 10.1159/000133593. [DOI] [PubMed] [Google Scholar]
  20. Johnsen L. B., Rasmussen L. K., Petersen T. E., Berglund L. Characterization of three types of human alpha s1-casein mRNA transcripts. Biochem J. 1995 Jul 1;309(Pt 1):237–242. doi: 10.1042/bj3090237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Jänicke F., Schmitt M., Pache L., Ulm K., Harbeck N., Höfler H., Graeff H. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat. 1993;24(3):195–208. doi: 10.1007/BF01833260. [DOI] [PubMed] [Google Scholar]
  22. Kunz C., Lönnerdal B. Casein and casein subunits in preterm milk, colostrum, and mature human milk. J Pediatr Gastroenterol Nutr. 1990 May;10(4):454–461. doi: 10.1097/00005176-199005000-00007. [DOI] [PubMed] [Google Scholar]
  23. Loh Y. P., Brownstein M. J., Gainer H. Proteolysis in neuropeptide processing and other neural functions. Annu Rev Neurosci. 1984;7:189–222. doi: 10.1146/annurev.ne.07.030184.001201. [DOI] [PubMed] [Google Scholar]
  24. Lottspeich F., Henschen A., Brantl V., Teschemacher H. Novel opioid peptides derived from casein (beta-casomorphins). III. Synthetic peptides corresponding to components from bovine casein peptone. Hoppe Seylers Z Physiol Chem. 1980 Dec;361(12):1835–1839. doi: 10.1515/bchm2.1980.361.2.1835. [DOI] [PubMed] [Google Scholar]
  25. Loukas S., Varoucha D., Zioudrou C., Streaty R. A., Klee W. A. Opioid activities and structures of alpha-casein-derived exorphins. Biochemistry. 1983 Sep 13;22(19):4567–4573. doi: 10.1021/bi00288a034. [DOI] [PubMed] [Google Scholar]
  26. Martin P., Leroux C. Exon-skipping is responsible for the 9 amino acid residue deletion occurring near the N-terminal of human beta-casein. Biochem Biophys Res Commun. 1992 Mar 16;183(2):750–757. doi: 10.1016/0006-291x(92)90547-x. [DOI] [PubMed] [Google Scholar]
  27. Meisel H. Chemical characterization and opioid activity of an exorphin isolated from in vivo digests of casein. FEBS Lett. 1986 Feb 17;196(2):223–227. doi: 10.1016/0014-5793(86)80251-4. [DOI] [PubMed] [Google Scholar]
  28. Meisel H., Frister H., Schlimme E. Biologically active peptides in milk proteins. Z Ernahrungswiss. 1989 Dec;28(4):267–278. doi: 10.1007/BF02019390. [DOI] [PubMed] [Google Scholar]
  29. Menon R. S., Chang Y. F., Jeffers K. F., Ham R. G. Exon skipping in human beta-casein. Genomics. 1992 Jan;12(1):13–17. doi: 10.1016/0888-7543(92)90400-m. [DOI] [PubMed] [Google Scholar]
  30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983 Dec 16;65(1-2):55–63. doi: 10.1016/0022-1759(83)90303-4. [DOI] [PubMed] [Google Scholar]
  31. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  32. Schlimme E., Meisel H. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Nahrung. 1995;39(1):1–20. doi: 10.1002/food.19950390102. [DOI] [PubMed] [Google Scholar]
  33. Tandon A. K., Clark G. M., Chamness G. C., Chirgwin J. M., McGuire W. L. Cathepsin D and prognosis in breast cancer. N Engl J Med. 1990 Feb 1;322(5):297–302. doi: 10.1056/NEJM199002013220504. [DOI] [PubMed] [Google Scholar]
  34. Teschemacher H., Koch G. Opioids in the milk. Endocr Regul. 1991 Sep;25(3):147–150. [PubMed] [Google Scholar]
  35. Threadgill D. W., Womack J. E. Genomic analysis of the major bovine milk protein genes. Nucleic Acids Res. 1990 Dec 11;18(23):6935–6942. doi: 10.1093/nar/18.23.6935. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES